ArticleJournal of cardiovascular translational research2026
Radiomics of Pericoronary Adipose Tissue and CT-FFR to Predict Major Adverse Cardiovascular Events in Patients with T2DM Complicated by CAD.
Article in Journal of cardiovascular translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Pericoronary Adipose Tissue Radiomics-Based Prediction Models for Cardiovascular Events: A Systematic Review of Predictive Performance, Validation, and Incremental Value.International journal of general medicine · 2026Review
- Preliminary exploration of the value of pericoronary adipose tissue radiomics in identifying high-risk patients with chronic coronary syndrome: a retrospective Chinese cohort study.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
This study aims to integrate lesion-specific pericoronary adipose tissue (PCAT) radiomics analysis with existing clinical and imaging methods under the guidance of CT-derived fractional flow reserve (CT-FFR), to develop and validate an interpretable machine learning (ML) prediction model for patients with type 2 diabetes complicated by coronary artery disease (CAD). The performance of ML algorithms across different predictive models was compared using the area under the receiver operating characteristic curve (AUC). In the validation cohort, the XGBoost algorithm within the combined model achieved an AUC value of 0.908, outperforming the best algorithm in the traditional model (AUC = 0.834) and radiomics model (AUC = 0.840). Meanwhile, the Shapley algorithm highlights the additional incremental value of radiomic features. Our model enhances the predictive ability and provides clinicians with a comprehensive tool, facilitating early intervention for high-risk individuals and proactive secondary prevention strategies, which may potentially improve clinical outcomes.
Indexed as
Identifiers
41639503What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.